(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CELLUBRIDGE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CELLUBRIDGE

ST13

US500000090377662

Class

5

Filing

90377662

Registration

8098144

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

60

Latest update

04/03/2026

Trademark type

Word

Nice classes

5

Filing date

12/12/2020

Registration date

01/13/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/13/2026

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

OTTAWA, CA

Examiner

MANGUBAT, ALEXANDER GEORGE

Law office

N30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

SPIDERWORT BIOTECHNOLOGIES INC.
Spiderwort Inc.

Representatives

R. Scott Keller WARNER NORCROSS + JUDD LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Neurological implants consisting of biological materialsimplants comprising living tissuecells and pharmacological agents

Publications

History of USPTO decisions and trademark events.

60 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/13/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/13/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/25/2025

PUBO

PUBLISHED FOR OPPOSITION

11/25/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/19/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/27/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/16/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/16/2025

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/16/2025

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/15/2025

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/15/2025

CNSI

SUSPENSION INQUIRY WRITTEN

10/15/2025

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

08/22/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/24/2025

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/21/2025

GNSL

LETTER OF SUSPENSION E-MAILED

02/21/2025

CNSL

SUSPENSION LETTER WRITTEN

02/21/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/20/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/20/2025

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/15/2025

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

11/26/2024

GNSI

INQUIRY TO SUSPENSION E-MAILED

11/26/2024

CNSI

SUSPENSION INQUIRY WRITTEN

11/26/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/27/2023

GNSL

LETTER OF SUSPENSION E-MAILED

12/27/2023

CNSL

SUSPENSION LETTER WRITTEN

12/27/2023

DPCC

DIVISIONAL PROCESSING COMPLETE

12/11/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/11/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/06/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/06/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

12/06/2023

DRRR

DIVISIONAL REQUEST RECEIVED

11/11/2023

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

11/11/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

09/08/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

09/08/2023

CNSI

SUSPENSION INQUIRY WRITTEN

09/08/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/03/2023

GNSL

LETTER OF SUSPENSION E-MAILED

03/03/2023

CNSL

SUSPENSION LETTER WRITTEN

03/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/01/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/01/2023

DOCK

ASSIGNED TO EXAMINER

03/01/2023

ALIE

ASSIGNED TO LIE

02/28/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

12/19/2022

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

07/13/2022

GNSI

INQUIRY TO SUSPENSION E-MAILED

07/13/2022

CNSI

SUSPENSION INQUIRY WRITTEN

07/13/2022

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

06/24/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/06/2021

GNSL

LETTER OF SUSPENSION E-MAILED

12/06/2021

CNSL

SUSPENSION LETTER WRITTEN

12/06/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/27/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/27/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/27/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/04/2021

GNRT

NON-FINAL ACTION E-MAILED

06/04/2021

CNRT

NON-FINAL ACTION WRITTEN

06/04/2021

DOCK

ASSIGNED TO EXAMINER

06/04/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/20/2021

NWAP

NEW APPLICATION ENTERED

12/16/2020

Continuous trademark protection

Get notified about every new filing that threatens CELLUBRIDGE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.